Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bio-Plexus Announces Patent Award.


VERNON, Conn.--(BW HealthWire)--June 29, 1998--Bio-Plexus, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:BPLX), designer, developer, manufacturer, and marketer of safety medical products under the PUNCTUR-GUARD(R) name, today announced it's DROP-IT(R) Needle Holder has been awarded patent protection from the United States Patent and Trademark Office The United States Patent and Trademark Office (PTO or USPTO) is an agency in the United States Department of Commerce that provides patent protection to inventors and businesses for their inventions, and trademark registration for product and intellectual property .

"The DROP-IT Needle Holder is designed for simple, one-handed disposal of blood-collection needles by healthcare workers. It features a push button for quick release, can be used with up to 100 PUNCTUR-GUARD or conventional needles, and will automatically release the needle when used with the DROP-IT Needle Disposal Container," according to according to
prep.
1. As stated or indicated by; on the authority of: according to historians.

2. In keeping with: according to instructions.

3.
 Tom Sutton, Executive Vice President of Marketing and Sales for Bio-Plexus. "The DROP-IT patent award strengthens our ability to deliver state-of-the-art safety medical devices to healthcare workers," he added.

The company holds U.S. and international patents on safety medical devices marketed under the PUNCTUR-GUARD name. These devices are designed to reduce the incidence of accidental needlesticks among healthcare workers. Accidental needlesticks number more than 950,000 per year in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  and can result in the transmission of deadly diseases including HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States.  and hepatitis.

NOTE: This press release may contain forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
, which are subject to change. The actual results may differ materially from those described in any forward-looking statement.

    CONTACT: Bio-Plexus, Inc.
              Carol Coburn, 860/870-6112
              bio.plexus@snet.net


COPYRIGHT 1998 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1998, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Article
Geographic Code:1USA
Date:Jun 22, 1998
Words:218
Previous Article:AEP Industries Completes Sale of Dutch Rigids Operations.
Next Article:Centurion Energy Announces Major Gas Discovery - Nile Delta, Egypt.
Topics:



Related Articles
Kaiser Permanente region to use Punctur-Guard needle.
Bio-Plexus reports 4th quarter/year end results; revenues rise 377% for 4th quarter, 242% for year.
University of Washington Hospital converts to Bio-Plexus Punctur-Guard(R) needle.
Bio-Plexus seeks approval to market Punctur-Guard(R) winged set; Second new product for blood collection to be introduced in 1996.
Prestigious hospitals in Miami and Philadelphia to use Bio-Plexus Punctur-Guard(R) needle.
Bio-Plexus needle chosen by two major hospitals; new generation machine installed.
Bio-Plexus reports second quarter/6 months results; Revenues rose 263 percent for six months.
Bio-Plexus signs agreement with division of AmeriNet.
Bio-Plexus Announces Patent Award.
Tough New Safety Needle Regulations Proposed.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles